Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsDrug Administration ScheduleCisplatinDoxorubicinCyclophosphamideCombined Modality TherapyTreatment OutcomeEtoposideLeukopeniaThrombocytopeniaDrug EvaluationNeutropeniaCarboplatinPaclitaxelSurvival AnalysisDisease-Free SurvivalIfosfamideInfusions, IntravenousNeoplasmsAntimetabolites, AntineoplasticLung NeoplasmsBone MarrowDeoxycytidineSurvival RateBone Marrow DiseasesVinblastineBreast NeoplasmsMethotrexateAntineoplastic Agents, AlkylatingNeoplasm StagingCytarabineTaxoidsNeoadjuvant TherapyHematologic DiseasesNauseaPrognosisAntineoplastic Agents, PhytogenicNeoplasm Recurrence, LocalDose-Response Relationship, DrugGranulocyte Colony-Stimulating FactorOrganoplatinum CompoundsDacarbazineSalvage TherapyLymphoma, Non-HodgkinVomiting6-MercaptopurineCamptothecinTopotecanDrug Resistance, NeoplasmMitoxantroneMaximum Tolerated DoseBleomycinCarmustineOvarian NeoplasmsLomustineNeoplasm MetastasisCarcinoma, Non-Small-Cell LungAntibiotics, AntineoplasticFollow-Up StudiesDaunorubicinTime FactorsInduction ChemotherapyLeukocyte CountHematopoiesisAdenocarcinomaBrain NeoplasmsClinical Trials as TopicRecurrenceMitomycinInfusions, ParenteralTransplantation, AutologousAlopeciaAdministration, OralBlood Cell CountFluorouracilMelphalanFocal Infection, DentalHodgkin DiseasePlatinum CompoundsPlatelet CountStomatitisRadiotherapyTegafurHematopoietic Stem Cell TransplantationBridged CompoundsSarcomaThiotepaVincristineCladribineColorectal NeoplasmsDental StaffAnthracyclinesBone NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaRadiotherapy DosageRemission InductionChemotherapy, Cancer, Regional PerfusionRadioimmunotherapy